Nuvalent (NUVL) Net Cash Flow (2020 - 2026)

Nuvalent (NUVL) reported Net Cash Flow of -$102.0 million for Q1 2026, down 310.41% on a YoY basis from $48.5 million in Q1 2025, and down 169.87% quarter-over-quarter from $146.0 million in Q4 2025.

Nuvalent (NUVL) Net Cash Flow (2020 - 2026) Analysis & Trends

Nuvalent has reported Net Cash Flow for 7 years, with the latest figure at -$102.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Cash Flow fell 310.41% year-over-year to -$102.0 million; the trailing twelve-month figure through Mar 2026 stood at $38.9 million (up 74.27% YoY), and the FY2025 full-year result was $116.1 million, up 161.18% from the prior year.
  • Net Cash Flow for Q1 2026 stood at -$102.0 million, down from $146.0 million in the prior quarter.
  • The five-year high for Net Cash Flow was $291.5 million in Q3 2024, with the low at -$236.9 million in Q1 2024.
  • Historically, Net Cash Flow has averaged $5.4 million across 5 years, with a median of -$1.3 million in 2022.
  • The largest YoY upside for Net Cash Flow was 4312.56% in 2023 against a maximum downside of 12006.23% in 2023.
  • Nuvalent's Net Cash Flow stood at $165.5 million in 2022, then soared by 49.22% to $247.0 million in 2023, then slumped by 190.52% to -$223.6 million in 2024, then jumped by 165.31% to $146.0 million in 2025, then tumbled by 169.87% to -$102.0 million in 2026.
  • The last three Net Cash Flow figures came in at -$102.0 million (Q1 2026), $146.0 million (Q4 2025), and -$11.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 2.44 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 625.70 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -2.44 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 457.40 Mn
9 Abivax 91.71 Bn 91.71 Bn - 664,983.53
10 Nuvalent 9.70 Bn 9.70 Bn - -102.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -102.01 Mn
Mar 31, 2026 -102.01 Mn
Dec 31, 2025 145.99 Mn
Dec 31, 2025 145.99 Mn
Sep 30, 2025 -11.72 Mn
Sep 30, 2025 -11.72 Mn
Jun 30, 2025 6.64 Mn
Jun 30, 2025 6.64 Mn
Mar 31, 2025 -24.86 Mn
Mar 31, 2025 -24.86 Mn
Dec 31, 2024 -223.55 Mn
Dec 31, 2024 -223.55 Mn
Sep 30, 2024 291.54 Mn
Sep 30, 2024 291.54 Mn
Jun 30, 2024 -20.82 Mn
Jun 30, 2024 -20.82 Mn
Mar 31, 2024 -236.87 Mn
Mar 31, 2024 -236.87 Mn
Dec 31, 2023 246.95 Mn
Dec 31, 2023 246.95 Mn